ERDRP-0519 is an antiviral drug which is the first drug specifically developed to target the measles morbillivirus. It acts as an inhibitor of the viral...

were published in November 2019. A specific drug treatment for measles, ERDRP-0519, has shown[when?] promising results in animal studies, but has not yet[when...

not progressed so far through development as JK-05.[citation needed] ERDRP-0519 Sofosbuvir Jourdan A (2014-10-14). "China military-linked firm eyes quick...